{
    "organizations": [],
    "uuid": "7d81c84447d69b43c46e77e85d741aa11c8314c2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-suven-life-sciences-gets-pr/brief-indias-suven-life-sciences-gets-product-patent-in-canada-idUSFWN1RG017",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Suven Life Sciences Gets Product Patent In Canada",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Suven Life Sciences Ltd:\n* GETS PRODUCT PATENT IN CANADA * PATENT CORRESPONDING TO NEW CHEMICAL ENTITY FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES\n* PATENT IS VALID THROUGH 2033 Source text - bit.ly/2pZFzag Further company coverage:\n ",
    "published": "2018-04-03T13:06:00.000+03:00",
    "crawled": "2018-04-04T12:25:31.024+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "suven",
        "life",
        "science",
        "ltd",
        "get",
        "product",
        "patent",
        "canada",
        "patent",
        "corresponding",
        "new",
        "chemical",
        "entity",
        "treatment",
        "disorder",
        "associated",
        "neurodegenerative",
        "disease",
        "patent",
        "valid",
        "source",
        "text",
        "company",
        "coverage"
    ]
}